4//SEC Filing
Ciambrone William 4
Accession 0001209191-22-017345
CIK 0000873303other
Filed
Mar 7, 7:00 PM ET
Accepted
Mar 8, 8:01 PM ET
Size
9.9 KB
Accession
0001209191-22-017345
Insider Transaction Report
Form 4
Transactions
- Award
Stock Option (right to buy)
2022-03-07+48,000→ 48,000 totalExercise: $80.42From: 2023-03-07Exp: 2032-03-07→ Common Stock (48,000 underlying) - Tax Payment
Common Stock
2022-03-04$79.20/sh−1,160$91,872→ 14,099 total - Award
Common Stock
2022-03-07+8,000→ 22,099 total
Footnotes (4)
- [F1]Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 3, 2021.
- [F2]The amount of securities directly owned by the reporting person includes the following shares of common stock purchased under the Company's Amended and Restated 2013 Employee Stock Purchase Plan: 77 shares on February 28, 2022, 75 shares on August 31, 2021, 62 shares on February 28, 2021 and 45 shares on August 31, 2020.
- [F3]The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. 25% of the shares of common stock underlying each RSU will vest on the first anniversary of the grant date, and additional 25% will vest on each anniversary of the Grant Date thereafter, such that the RSUs will be fully vested on the fourth anniversary of the grant date.
- [F4]Represents the date upon which the first 25% of the option granted vests. 1/48th of the total granted option vests and become exercisable on each monthly anniversary thereafter.
Documents
Issuer
Sarepta Therapeutics, Inc.
CIK 0000873303
Entity typeother
Related Parties
1- filerCIK 0001794135
Filing Metadata
- Form type
- 4
- Filed
- Mar 7, 7:00 PM ET
- Accepted
- Mar 8, 8:01 PM ET
- Size
- 9.9 KB